CD BioGlyco has a professional Recombinant Lectin Production and analysis team, and technical personnel has rich industry experience, equipped with international advanced instrument facilities, to provide clients with galactose-binding lectin production process of fast, high quality, professional, flexible integrated solutions.
We provide a one-stop service from gene synthesis to lectin preparation, and clients flexibly choose services or customized services according to their own needs.
Fig.1 Flow chart of galactose-binding lectin production. (CD BioGlyco)
Galactose-binding Lectin Production Service at CD BioGlyco
Galactose-binding lectins have a high selective binding specificity for detecting the isolation of specific carbohydrates. Meanwhile, galectin recombinant proteins are used to purify proteins containing specific glycosylation.
Galactose-binding lectins are labeled on the cell surface as vital probes to track and localize the expression and distribution of specific glycosylation structures in the cells.
Because the glycosylation structure on the cell surface of some diseases deviates from normal cells, such as galactose-binding lectin recombinant protein as a new target for cancer biomarker analysis and detection.
Galactose-binding lectin has enhanced the activity of the immune system and promotes inflammatory response and antiviral effects. It is the active component of potential immunotherapeutic agents.
High expression of galactose-binding lectin is protective in inflammatory liver injury and is used as a potential target for the treatment of acute liver disease. It facilitates hepatocellular carcinoma (HCC) cell adhesion to the cytoplasmic matrix, cell migration, and invasion, and plays a role in suppressing anti-tumor immune response.
Galactose-binding lectin is a major immunosuppressive factor that contributes to the tumor immune escape process and regulates the functions and viability of tumor-specific T cells.
Galactose-binding lectin promotes intestinal wound healing and has protective effects on the intestinal epithelial barrier.
Advantage of Us
We provide complete production services ranging from conceptual design, gene optimization, and expression condition optimization to purification. In addition, we provide the target object follow-up testing services.
Our company offers purity recombinant galactose-binding lectin production services from mg to g.
Nio-Kobayashi, J. Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease. Anat Sci Int. 2017, 92(1): 25-36.
This service is for Research Use Only, not intended for any clinical use.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
Fig.1 Flow chart of galactose-binding lectin production. (CD BioGlyco)
